-
1
-
-
80055122337
-
Optimal primary surgical treatment for advanced epithelial ovarian cancer
-
A. Elattar, A. Bryant, and B.A. Winter-Roach et al. Optimal primary surgical treatment for advanced epithelial ovarian cancer Cochrane Database Syst Rev 10 8 2011 Aug
-
(2011)
Cochrane Database Syst Rev
, vol.10
, Issue.8
-
-
Elattar, A.1
Bryant, A.2
Winter-Roach, B.A.3
-
2
-
-
80053623186
-
Prognostic factors for patients treated for a recurrent FIGO stage III ovarian cancer: A retrospective study of 108 cases
-
J.M. Classe, I. Jaffre, and J.S. Frenel et al. Prognostic factors for patients treated for a recurrent FIGO stage III ovarian cancer: a retrospective study of 108 cases Eur J Surg Oncol 2011 971 977
-
(2011)
Eur J Surg Oncol
, pp. 971-977
-
-
Classe, J.M.1
Jaffre, I.2
Frenel, J.S.3
-
4
-
-
57649083923
-
Cytoreductive surgery for recurrent ovarian cancer: A meta-analysis
-
R.E. Bristow, I. Puri, and D.S. Chi Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis Gynecol Oncol 112 2009 256 274
-
(2009)
Gynecol Oncol
, vol.112
, pp. 256-274
-
-
Bristow, R.E.1
Puri, I.2
Chi, D.S.3
-
6
-
-
84858232676
-
Extraperitoneal metastases from recurrent ovarian cancer
-
W.R. Robinson, J. Beyer, and S. Griffin et al. Extraperitoneal metastases from recurrent ovarian cancer Int J Gynecol Cancer 22 2012 43 46
-
(2012)
Int J Gynecol Cancer
, vol.22
, pp. 43-46
-
-
Robinson, W.R.1
Beyer, J.2
Griffin, S.3
-
7
-
-
33846018958
-
Isolated lymph node relapse of epithelial ovarian carcinoma: Outcomes and prognostic factors
-
P. Blanchard, A. Plantade, and C. Pages et al. Isolated lymph node relapse of epithelial ovarian carcinoma: outcomes and prognostic factors Gynecol Oncol 104 2007 41 45
-
(2007)
Gynecol Oncol
, vol.104
, pp. 41-45
-
-
Blanchard, P.1
Plantade, A.2
Pages, C.3
-
8
-
-
61349116871
-
Epithelial ovarian cancer relapsing as isolated lymph node disease: Natural history and clinical outcome
-
F. Legge, M. Petrillo, and V. Adamo et al. Epithelial ovarian cancer relapsing as isolated lymph node disease: natural history and clinical outcome BMC Cancer 8 2008 367
-
(2008)
BMC Cancer
, vol.8
, pp. 367
-
-
Legge, F.1
Petrillo, M.2
Adamo, V.3
-
9
-
-
0043167991
-
Lymph node involvement in epithelial ovarian cancer: Analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications
-
P. Morice, F. Joulie, and S. Camatte et al. Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications J Am Coll Surg 197 2003 198 205
-
(2003)
J Am Coll Surg
, vol.197
, pp. 198-205
-
-
Morice, P.1
Joulie, F.2
Camatte, S.3
-
10
-
-
0000335247
-
FIGO staging of ovarian cancer. from FIGO Cancer Committee Staging Announcement
-
FIGO staging of ovarian cancer. From FIGO Cancer Committee Staging Announcement Gynecol Oncol 25 1986 383 385
-
(1986)
Gynecol Oncol
, vol.25
, pp. 383-385
-
-
-
11
-
-
77957568499
-
The impact of systematic para-aortic and pelvic lymphadenectomy on survival in patients with optimally debulked ovarian cancer
-
A. Abe, A. Furumoto, and Irahara et al. The impact of systematic para-aortic and pelvic lymphadenectomy on survival in patients with optimally debulked ovarian cancer J Obstet Gynaecol Res 36 5 2010 Oct 1023 1030
-
(2010)
J Obstet Gynaecol Res
, vol.36
, Issue.5
, pp. 1023-1030
-
-
Abe, A.1
Furumoto, A.2
Irahara3
-
12
-
-
34748902355
-
Ovarian cancer patients with "node-positive-only" Stage IIIC disease have a more favorable outcome than Stage IIIA/B
-
G. Ferrandina, G. Scambia, and F. Legge et al. Ovarian cancer patients with "node-positive-only" Stage IIIC disease have a more favorable outcome than Stage IIIA/B Gynecol Oncol 107 2007 154 156
-
(2007)
Gynecol Oncol
, vol.107
, pp. 154-156
-
-
Ferrandina, G.1
Scambia, G.2
Legge, F.3
-
13
-
-
33751433344
-
Is it justified to classify patients to Stage IIIC epithelial ovarian cancer based on nodal involvement only?
-
W.A. Cliby, G.D. Aletti, and T.O. Wilson et al. Is it justified to classify patients to Stage IIIC epithelial ovarian cancer based on nodal involvement only? Gynecol Oncol 103 2006 797 801
-
(2006)
Gynecol Oncol
, vol.103
, pp. 797-801
-
-
Cliby, W.A.1
Aletti, G.D.2
Wilson, T.O.3
-
14
-
-
0037440295
-
Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant Chemotherapy in Ovarian Neoplasm trial
-
European Organisation for Research and Treatment of Cancer-Adjuvant Chemotherapy in Ovarian Neoplasm
-
J.B. Trimbos, I. Vergote, G. Bolis European Organisation for Research and Treatment of Cancer-Adjuvant Chemotherapy in Ovarian Neoplasm Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant Chemotherapy in Ovarian Neoplasm trial J Natl Cancer Inst 95 2003 113 125
-
(2003)
J Natl Cancer Inst
, vol.95
, pp. 113-125
-
-
Trimbos, J.B.1
Vergote, I.2
Bolis, G.3
-
15
-
-
20244376152
-
Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: A randomized clinical trial
-
P. Benedetti Panici, A. Maggioni, and N. Hacker et al. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial J Natl Cancer Inst 97 2005 560 566
-
(2005)
J Natl Cancer Inst
, vol.97
, pp. 560-566
-
-
Benedetti Panici, P.1
Maggioni, A.2
Hacker, N.3
-
16
-
-
33644845467
-
Does aggressive surgery only benefit patients with less advanced ovarian cancer? Results from an international comparison within the SCOTROC-1 trial
-
S.C. Crawford, P.A. Vasey, and J. Paul et al. Does aggressive surgery only benefit patients with less advanced ovarian cancer? Results from an international comparison within the SCOTROC-1 trial J Clin Oncol 23 2005 8802 8811
-
(2005)
J Clin Oncol
, vol.23
, pp. 8802-8811
-
-
Crawford, S.C.1
Vasey, P.A.2
Paul, J.3
-
17
-
-
35948966883
-
The role of lymphadenectomy in advanced epithelial ovarian cancer in patients with macroscopically complete resection of intraperitoneal disease
-
A. Du Bois, A. Reuss, and P. Harter The role of lymphadenectomy in advanced epithelial ovarian cancer in patients with macroscopically complete resection of intraperitoneal disease Int J Gynecol Cancer 16 S3 2006 599 615
-
(2006)
Int J Gynecol Cancer
, vol.16
, Issue.3
, pp. 599-615
-
-
Du Bois, A.1
Reuss, A.2
Harter, P.3
-
18
-
-
0020574567
-
Survival of patients following secondary cytoreductive surgery in ovarian cancer
-
J.S. Berek, N.F. Hacker, and L.D. Lagasse Survival of patients following secondary cytoreductive surgery in ovarian cancer Obstet Gynecol 61 1983 189 193
-
(1983)
Obstet Gynecol
, vol.61
, pp. 189-193
-
-
Berek, J.S.1
Hacker, N.F.2
Lagasse, L.D.3
-
19
-
-
0028786870
-
Secondary cytoreductive surgery for recurrent ovarian cancer: A prospective study
-
S.M. Eisenkop, R.L. Friedman, and H.J. Wang Secondary cytoreductive surgery for recurrent ovarian cancer: a prospective study Cancer 76 1995 1606 1614
-
(1995)
Cancer
, vol.76
, pp. 1606-1614
-
-
Eisenkop, S.M.1
Friedman, R.L.2
Wang, H.J.3
-
20
-
-
34548130199
-
Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma
-
S.J. Tebes, R.A. Sayer, and J.M. Palmer et al. Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma Gynecol Oncol 106 2007 482 487
-
(2007)
Gynecol Oncol
, vol.106
, pp. 482-487
-
-
Tebes, S.J.1
Sayer, R.A.2
Palmer, J.M.3
-
21
-
-
34250223484
-
Secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer
-
P. Benedetti Panici, A. De Vivo, and F. Bellati et al. Secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer Ann Surg Oncol 14 2007 1136 1142
-
(2007)
Ann Surg Oncol
, vol.14
, pp. 1136-1142
-
-
Benedetti Panici, P.1
De Vivo, A.2
Bellati, F.3
-
22
-
-
34748864735
-
Bulky lymph node resection in patients with recurrent epithelial ovarian cancer: Impact of surgery
-
P. Benedetti Panici, G. Perniola, and R. Angioli et al. Bulky lymph node resection in patients with recurrent epithelial ovarian cancer: impact of surgery Int J Gynecol Cancer 17 2007 1245 1251
-
(2007)
Int J Gynecol Cancer
, vol.17
, pp. 1245-1251
-
-
Benedetti Panici, P.1
Perniola, G.2
Angioli, R.3
-
23
-
-
78349260017
-
Role of secondary cytoreductive surgery in ovarian cancer relapse: Who will benefit? A systematic analysis of 240 consecutive patients
-
J. Sehouli, R. Richter, and E.I. Braicu et al. Role of secondary cytoreductive surgery in ovarian cancer relapse: who will benefit? A systematic analysis of 240 consecutive patients J Surg Oncol 102 2010 656 662
-
(2010)
J Surg Oncol
, vol.102
, pp. 656-662
-
-
Sehouli, J.1
Richter, R.2
Braicu, E.I.3
-
24
-
-
33845657404
-
Surgery in recurrent ovarian cancer - The Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial
-
P. Harter, A. du Bois, and M. Hahmann et al. Surgery in recurrent ovarian cancer - the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial Ann Surg Oncol 13 2006 1702 1710
-
(2006)
Ann Surg Oncol
, vol.13
, pp. 1702-1710
-
-
Harter, P.1
Du Bois, A.2
Hahmann, M.3
-
25
-
-
78349280245
-
Survival after secondary cytoreduction for recurrent ovarian cancer: Which are the prognostic factors?
-
I. Biliatis, D.D. Haidopoulos, and A. Rodolakis et al. Survival after secondary cytoreduction for recurrent ovarian cancer: which are the prognostic factors? J Surg Oncol 102 2010 671 675
-
(2010)
J Surg Oncol
, vol.102
, pp. 671-675
-
-
Biliatis, I.1
Haidopoulos, D.D.2
Rodolakis, A.3
-
26
-
-
78649907488
-
Surgical management of recurrent ovarian cancer: The advantage of collaborative surgical management and a multidisciplinary approach
-
E. Burton, D. Chase, and M. Yamamoto et al. Surgical management of recurrent ovarian cancer: the advantage of collaborative surgical management and a multidisciplinary approach Gynecol Oncol 120 2011 29 32
-
(2011)
Gynecol Oncol
, vol.120
, pp. 29-32
-
-
Burton, E.1
Chase, D.2
Yamamoto, M.3
-
27
-
-
0018569942
-
A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate
-
J.H. Goldie, and A.J. Coldman A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate Cancer Treat Rep 63 1979 1727 1733
-
(1979)
Cancer Treat Rep
, vol.63
, pp. 1727-1733
-
-
Goldie, J.H.1
Coldman, A.J.2
-
28
-
-
84866183391
-
The role of secondary surgery in recurrent ovarian cancer
-
10.1155/2012/613980 [Epub 2012 Aug 5]
-
D. Lorusso, M. Mancini, and R. Di Rocco et al. The role of secondary surgery in recurrent ovarian cancer Int J Surg Oncol 2012 10.1155/2012/613980 [Epub 2012 Aug 5]
-
(2012)
Int J Surg Oncol
-
-
Lorusso, D.1
Mancini, M.2
Di Rocco, R.3
-
29
-
-
0034941943
-
The clinical significance of occult macroscopically positive retroperitoneal nodes in patients with epithelial ovarian cancer
-
S.M. Eisenkop, and N.M. Spirtos The clinical significance of occult macroscopically positive retroperitoneal nodes in patients with epithelial ovarian cancer Gynecol Oncol 82 2001 143 149
-
(2001)
Gynecol Oncol
, vol.82
, pp. 143-149
-
-
Eisenkop, S.M.1
Spirtos, N.M.2
-
30
-
-
75749098037
-
The clinical outcome of epithelial ovarian cancer patients with apparently isolated lymph node recurrence: A multicenter retrospective Italian study
-
A. Gadducci, S. Cosio, and P. Zola et al. The clinical outcome of epithelial ovarian cancer patients with apparently isolated lymph node recurrence: a multicenter retrospective Italian study Gynecol Oncol 116 2010 358 363
-
(2010)
Gynecol Oncol
, vol.116
, pp. 358-363
-
-
Gadducci, A.1
Cosio, S.2
Zola, P.3
-
31
-
-
0036074798
-
Local radiation therapy for localized relapsed or refractory ovarian cancer patients with or without symptoms after chemotherapy
-
K. Fujiwara, S. Suzuki, and E. Yoden et al. Local radiation therapy for localized relapsed or refractory ovarian cancer patients with or without symptoms after chemotherapy Int J Gynecol Cancer 12 2002 250 256
-
(2002)
Int J Gynecol Cancer
, vol.12
, pp. 250-256
-
-
Fujiwara, K.1
Suzuki, S.2
Yoden, E.3
-
32
-
-
67549118434
-
Secondary cytoreductive surgery in patients presenting with isolated nodal recurrence of epithelial ovarian cancer
-
S. Fotiou, T. Aliki, and Z. Petros et al. Secondary cytoreductive surgery in patients presenting with isolated nodal recurrence of epithelial ovarian cancer Gynecol Oncol 114 2009 178 182
-
(2009)
Gynecol Oncol
, vol.114
, pp. 178-182
-
-
Fotiou, S.1
Aliki, T.2
Petros, Z.3
-
33
-
-
16644388431
-
Outcomes after combined therapy including surgical resection in patients with epithelial ovarian cancer recurrence(s) exclusively in lymph nodes
-
C. Uzan, P. Morice, and A. Rey et al. Outcomes after combined therapy including surgical resection in patients with epithelial ovarian cancer recurrence(s) exclusively in lymph nodes Ann Surg Oncol 11 2004 658 664
-
(2004)
Ann Surg Oncol
, vol.11
, pp. 658-664
-
-
Uzan, C.1
Morice, P.2
Rey, A.3
-
34
-
-
33846903602
-
Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer
-
A. Santillan, A.K. Karam, and A.J. Li et al. Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer Gynecol Oncol 104 2007 686 690
-
(2007)
Gynecol Oncol
, vol.104
, pp. 686-690
-
-
Santillan, A.1
Karam, A.K.2
Li, A.J.3
|